CYTORI THERAPEUTICS INC - COM NEW (CYTX)

CUSIP: 23283K204

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
3,000,477
Share change
-79,798
Total reported value
$4,531,000
Put/Call ratio
118%
Price per share
$1.51
Number of holders
24
Value change
-$137,646
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 23283K204?
CUSIP 23283K204 identifies CYTX - CYTORI THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM NEW (CYTX) as of Q4 2016

As of 31 Dec 2016, CYTORI THERAPEUTICS INC - COM NEW (CYTX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,000,477 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Creative Planning, GEODE CAPITAL MANAGEMENT, LLC, KCG HOLDINGS, INC., BlackRock Fund Advisors, CITADEL ADVISORS LLC, and SIMPLEX TRADING, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.